AstraZeneca Announced as a Sponsor of the National Symposium on Anemia Renal Research
Bethesda, MD – The Medical Technology and Practice Patterns Institute (MTPPI – mtppi.org) announced that AstraZeneca has agreed to serve as the Conference Welcome Sponsor for the National Symposium on Anemia Renal Research ( www.RenalAnemiaResearch.org ). “AstraZeneca leads by example when it comes to deploying and supporting patient-centered research frameworks,” said Nicholas Hamilton-Cotter, Director of Development and Strategic Alliances at MTPPI. “Dr. Jim Sloand and the Renal team at AstraZeneca have been important contributors to the Patient Research Agenda for Improved Kidney Care Outcomes (PRAIKCO) planning meetings and we thank them for their generous support of the upcoming National Symposium weekend.”
About AstraZeneca: AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular, Renal & Metabolism and Respiratory. Specifically in renal, as a company, we continue to explore medicines that could potentially address multiple points of the chronic kidney disease (CKD) journey – from modifying the progression of the disease itself to managing potentially life-threatening complications such as hyperkalaemia and anaemia that may arise in later stages of CKD. We are determined to make a difference for patients with CKD. www.AstraZeneca.com
About the Patient Research Agenda for Improved Kidney Care Outcomes (PRAIKCO) National Symposium: The National Symposium weekend ( www.RenalAnemiaResearch.org ) is the culmination of a two-year long initiative led by the Medical Technology and Practice Patterns Institute. The goal of the Symposium weekend is to compile an integrated list of research priorities and potential strategies to improve dialysis care in real-world, clinical settings. Attendees will give recommendations for research questions while working towards consensus on priority topics, research design considerations, data collection strategies, reporting and dissemination channels, anemia management policy making opportunities, and patient education strategies. Final deliverables will be used to inform future research, policy, and clinical practice.
About the Medical Technology and Practice Patterns Institute, Inc. (MTPPI): Medical Technology and Practice Patterns Institute (MTPPI – mtppi.org) is a nonprofit organization established in 1986 to conduct research on the clinical and economic implications of health care technologies. MTPPI’s research is directed toward the formulation and implementation of local and national health care policies. With extensive investigator experience in both the public and private sectors, MTPPI’s staff designs, implements, and conducts a full range of healthcare research and technology development activities. Our staff includes statisticians, epidemiologists, economists, programmers, biomedical engineers, and policy analysts. We specialize in using big data to conduct “real-time”, “real-world” studies that are both affordable and useful for healthcare stakeholders.
Comments